Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 490 articles:
HTML format



Single Articles


    January 2022
  1. BAJOS N, Spire A, Silberzan L
    The social specificities of hostility toward vaccination against Covid-19 in France.
    PLoS One. 2022;17:e0262192.
    PubMed     Abstract available


  2. PATEL SM, Shaik-Dasthagirisaheb YB, Congdon M, Young RR, et al
    Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2022;17:e0262225.
    PubMed     Abstract available


  3. NG OMBE H, Simuyandi M, Mwaba J, Luchen CC, et al
    Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol) in adults residing in Lukanga Swamps of Zambia.
    PLoS One. 2022;17:e0262239.
    PubMed     Abstract available


  4. RINTA-KOKKO H, Palmu AA, Ruokokoski E, Nieminen H, et al
    Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial.
    PLoS One. 2022;17:e0261750.
    PubMed     Abstract available


  5. YOUNG-XU Y, Smith J, Nealon J, Mahmud SM, et al
    Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans.
    PLoS One. 2022;17:e0262072.
    PubMed     Abstract available


  6. LEE C, Holroyd TA, Gur-Arie R, Sauer M, et al
    COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy.
    PLoS One. 2022;17:e0261929.
    PubMed     Abstract available


  7. AKTHER T, Nur T
    A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use.
    PLoS One. 2022;17:e0261869.
    PubMed     Abstract available


  8. GHADDAR A, Khandaqji S, Awad Z, Kansoun R, et al
    Conspiracy beliefs and vaccination intent for COVID-19 in an infodemic.
    PLoS One. 2022;17:e0261559.
    PubMed     Abstract available


  9. SIEWE N, Friedman A
    Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model.
    PLoS One. 2022;17:e0262453.
    PubMed     Abstract available


  10. TEERAWATTANANON Y, Anothaisintawee T, Pheerapanyawaranun C, Botwright S, et al
    A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.
    PLoS One. 2022;17:e0261930.
    PubMed     Abstract available


  11. SEO J, Lim J
    The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019.
    PLoS One. 2022;17:e0262594.
    PubMed     Abstract available


  12. STRICKLAND JC, Reed DD, Hursh SR, Schwartz LP, et al
    Behavioral economic methods to inform infectious disease response: Prevention, testing, and vaccination in the COVID-19 pandemic.
    PLoS One. 2022;17:e0258828.
    PubMed     Abstract available


  13. WISNEWSKI AV, Liu J, Lucas C, Klein J, et al
    Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses.
    PLoS One. 2022;17:e0262657.
    PubMed     Abstract available


  14. YOKOTA H, Hayashi H, Hanaguri J, Yamagami S, et al
    Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes.
    PLoS One. 2022;17:e0262568.
    PubMed     Abstract available


  15. DIRIRSA K, Makuria M, Mulu E, Deriba BS, et al
    Assessment of vaccination timeliness and associated factors among children in Toke Kutaye district, central Ethiopia: A Mixed study.
    PLoS One. 2022;17:e0262320.
    PubMed     Abstract available


  16. RAUT S, Apte A, Srinivasan M, Dudeja N, et al
    Determinants of maternal influenza vaccination in the context of low- and middle-income countries: A systematic review.
    PLoS One. 2022;17:e0262871.
    PubMed     Abstract available


  17. MOSE A, Haile K, Timerga A
    COVID-19 vaccine hesitancy among medical and health science students attending Wolkite University in Ethiopia.
    PLoS One. 2022;17:e0263081.
    PubMed     Abstract available


  18. RAMATILLAH DL, Gan SH, Pratiwy I, Syed Sulaiman SA, et al
    Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.
    PLoS One. 2022;17:e0262438.
    PubMed     Abstract available


  19. LIAO CC, Tai YH, Yeh CC, Hsu YH, et al
    Effect of influenza vaccination on the outcomes of hospitalization for kidney disease in a geriatric population: A propensity-score matched study.
    PLoS One. 2022;17:e0262420.
    PubMed     Abstract available


  20. AMINUDDIN F, Zaimi NA, Mohd Nor Sham Kunusagaran MSJ, Bahari MS, et al
    Cost-effectiveness and budget impact analysis of PPV23 vaccination for the Malaysian Hajj pilgrims.
    PLoS One. 2022;17:e0262949.
    PubMed     Abstract available


  21. BELL S, Clarke RM, Ismail SA, Ojo-Aromokudu O, et al
    COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: A mixed-methods study.
    PLoS One. 2022;17:e0260949.
    PubMed     Abstract available


  22. NERY N JR, Ticona JPA, Cardoso CW, Prates APPB, et al
    COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.
    PLoS One. 2022;17:e0262649.
    PubMed     Abstract available


  23. NISAR MI, Jehan F, Shahid S, Ahmed S, et al
    Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan.
    PLoS One. 2022;17:e0262466.
    PubMed     Abstract available


  24. OCAN M, Acheng F, Otike C, Beinomugisha J, et al
    Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda.
    PLoS One. 2022;17:e0262126.
    PubMed     Abstract available


  25. KORANG SK, von Rohden E, Veroniki AA, Ong G, et al
    Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.
    PLoS One. 2022;17:e0260733.
    PubMed     Abstract available


  26. OHMURA H
    Analysis of social combinations of COVID-19 vaccination: Evidence from a conjoint analysis.
    PLoS One. 2022;17:e0261426.
    PubMed     Abstract available


  27. CHEN PY, Chuang PN, Chiang CH, Chang HH, et al
    Impact of Coronavirus Infectious Disease (COVID-19) pandemic on willingness of immunization-A community-based questionnaire study.
    PLoS One. 2022;17:e0262660.
    PubMed     Abstract available


  28. TLALE LB, Gabaitiri L, Totolo LK, Smith G, et al
    Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
    PLoS One. 2022;17:e0263375.
    PubMed     Abstract available


  29. PETROVIC V, Vukovic V, Patic A, Markovic M, et al
    Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection-A comparative study from Novi Sad, Serbia.
    PLoS One. 2022;17:e0263468.
    PubMed     Abstract available


  30. BEARTH A, Berthold A, Siegrist M
    People's perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats.
    PLoS One. 2022;17:e0263351.
    PubMed     Abstract available


  31. VOIGT A, Omholt S, Almaas E
    Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    PLoS One. 2022;17:e0263155.
    PubMed     Abstract available


  32. PRATAMA NR, Wafa IA, Budi DS, Putra M, et al
    mRNA Covid-19 vaccines in pregnancy: A systematic review.
    PLoS One. 2022;17:e0261350.
    PubMed     Abstract available


  33. RONCHINI C, Gandini S, Pasqualato S, Mazzarella L, et al
    Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs.
    PLoS One. 2022;17:e0263014.
    PubMed     Abstract available


  34. MEMIRIE ST, Yigezu A, Zewdie SA, Mirkuzie AH, et al
    Hospitalization costs for COVID-19 in Ethiopia: Empirical data and analysis from Addis Ababa's largest dedicated treatment center.
    PLoS One. 2022;17:e0260930.
    PubMed     Abstract available


  35. JANOWSKI AB, Polgreen PM, Beekmann SE, Newland JG, et al
    Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey.
    PLoS One. 2022;17:e0263767.
    PubMed     Abstract available


  36. MAOR Y, Caspi S
    Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population.
    PLoS One. 2022;17:e0255495.
    PubMed     Abstract available


  37. HOSSIAN M, Khan MAS, Nazir A, Nabi MH, et al
    Factors affecting intention to take COVID-19 vaccine among Pakistani University Students.
    PLoS One. 2022;17:e0262305.
    PubMed     Abstract available


  38. DAVIS B, Krautmann M, Leroueil PR
    A method for estimating the impact of new vaccine technologies on vaccination coverage rates.
    PLoS One. 2022;17:e0263612.
    PubMed     Abstract available


  39. BASSI J, Giannini O, Silacci-Fregni C, Pertusini L, et al
    Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
    PLoS One. 2022;17:e0263328.
    PubMed     Abstract available


  40. ALHENDYANI F, Jolly K, Jones LL
    Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis.
    PLoS One. 2022;17:e0263234.
    PubMed     Abstract available


  41. MONSTED B, Lehmann S
    Characterizing polarization in online vaccine discourse-A large-scale study.
    PLoS One. 2022;17:e0263746.
    PubMed     Abstract available


  42. SINGH K, Lima G, Cha M, Cha C, et al
    Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic.
    PLoS One. 2022;17:e0263381.
    PubMed     Abstract available


  43. JUNG BK, An YH, Jang JJ, Jeon JH, et al
    The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate.
    PLoS One. 2022;17:e0263684.
    PubMed     Abstract available


  44. EGLOFF C, Couffignal C, Cordier AG, Deruelle P, et al
    Pregnant women's perceptions of the COVID-19 vaccine: A French survey.
    PLoS One. 2022;17:e0263512.
    PubMed     Abstract available


  45. ZHOU L, Ampon-Wireko S, Xu X, Quansah PE, et al
    Media attention and Vaccine Hesitancy: Examining the mediating effects of Fear of COVID-19 and the moderating role of Trust in leadership.
    PLoS One. 2022;17:e0263610.
    PubMed     Abstract available


  46. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: Prevision vs. reality of Bangladesh context.
    PLoS One. 2022;17:e0263078.
    PubMed     Abstract available


  47. LAMORI J, Feng X, Pericone CD, Mesa-Frias M, et al
    Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults.
    PLoS One. 2022;17:e0264062.
    PubMed     Abstract available


  48. JAMISON AF, McCormick BJJ, Hussain E, Thomas ED, et al
    Determinants of vaccine coverage and timeliness in a northern Pakistani village.
    PLoS One. 2022;17:e0263712.
    PubMed     Abstract available


  49. ROBERTS HA, Clark DA, Kalina C, Sherman C, et al
    To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability.
    PLoS One. 2022;17:e0264019.
    PubMed     Abstract available


  50. KANE PB, Moyer H, MacPherson A, Papenburg J, et al
    Relationship between lay and expert perceptions of COVID-19 vaccine development timelines in Canada and USA.
    PLoS One. 2022;17:e0262740.
    PubMed     Abstract available


  51. DIEHL C, Hunkler C
    Vaccination-related attitudes and behavior across birth cohorts: Evidence from Germany.
    PLoS One. 2022;17:e0263871.
    PubMed     Abstract available


  52. BUDZIAR W, Gembara K, Harhala M, Szymczak A, et al
    Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    PLoS One. 2022;17:e0253638.
    PubMed     Abstract available


  53. ENYEW EB, Tareke AA
    Vaccination status and factors associated among children age 12-23 months in Ethiopia, based on 2016 EDHS: Logit based multinomial logistic regression analysis.
    PLoS One. 2022;17:e0264004.
    PubMed     Abstract available


  54. ADEDEJI-ADENOLA H, Olugbake OA, Adeosun SA
    Factors influencing COVID-19 vaccine uptake among adults in Nigeria.
    PLoS One. 2022;17:e0264371.
    PubMed     Abstract available


  55. MAMUTI S, Tabu C, Marete I, Opili D, et al
    Measles containing vaccine coverage and factors associated with its uptake among children aged 24-59 months in Cherangany Sub County, Trans Nzoia County, Kenya.
    PLoS One. 2022;17:e0263780.
    PubMed     Abstract available


  56. YOUSSEF D, Abou-Abbas L, Berry A, Youssef J, et al
    Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model.
    PLoS One. 2022;17:e0264128.
    PubMed     Abstract available


  57. BSOUL EA, Loomer PM
    COVID-19 vaccination experience among United States dental professionals and students: Safety, confidence, concerns, and side effects.
    PLoS One. 2022;17:e0264323.
    PubMed     Abstract available


  58. BONHOMME ME, Bonhomme CJ, Strelow L, Chaudhari A, et al
    Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
    PLoS One. 2022;17:e0262922.
    PubMed     Abstract available


  59. LI H, Ren H, Zhou Y, Zhang Y, et al
    HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice.
    PLoS One. 2022;17:e0262231.
    PubMed     Abstract available


  60. ACKHTER MM, Shahid ASMSB, Ahmed T, Palit P, et al
    Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guerin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh.
    PLoS One. 2022;17:e0262391.
    PubMed     Abstract available


  61. STRUPAT C, Shigute Z, Bedi AS, Rieger M, et al
    Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
    PLoS One. 2022;17:e0264633.
    PubMed     Abstract available


  62. ROMERO-IBARGUENGOITIA ME, Rivera-Salinas D, Hernandez-Ruiz YG, Armendariz-Vazquez AG, et al
    Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.
    PLoS One. 2022;17:e0263942.
    PubMed     Abstract available


  63. PAVIC Z, Suljok A
    Vaccination conspiracy beliefs among social science & humanities and STEM educated people-An analysis of the mediation paths.
    PLoS One. 2022;17:e0264722.
    PubMed     Abstract available


  64. FOJNICA A, Osmanovic A, Duzic N, Fejzic A, et al
    COVID-19 vaccine acceptance and rejection in an adult population in Bosnia and Herzegovina.
    PLoS One. 2022;17:e0264754.
    PubMed     Abstract available


  65. SANDOR J, Vincze F, Shrikant ML, Korosi L, et al
    COVID-19 vaccination coverage in deprived populations living in segregated colonies: A nationwide cross-sectional study in Hungary.
    PLoS One. 2022;17:e0264363.
    PubMed     Abstract available


  66. TSUNETSUGU-YOKOTA Y, Ito S, Adachi Y, Onodera T, et al
    Saliva as a useful tool for evaluating upper mucosal antibody response to influenza.
    PLoS One. 2022;17:e0263419.
    PubMed     Abstract available


  67. ELIES A, Bonneau C, Houzard S, Rouzier R, et al
    Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.
    PLoS One. 2022;17:e0264821.
    PubMed     Abstract available


  68. FREUDENBERGER CATANZARO KC, Lahmers KK, Allen IC, Inzana TJ, et al
    Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle.
    PLoS One. 2022;17:e0259807.
    PubMed     Abstract available


  69. GEORGE CE, Inbaraj LR, Rajukutty S, Joan RF, et al
    Seroprevalence of COVID-19 infection among vaccine naive population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study.
    PLoS One. 2022;17:e0265236.
    PubMed     Abstract available


  70. CHUKWU CA, Mahmood K, Elmakki S, Gorton J, et al
    Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.
    PLoS One. 2022;17:e0265130.
    PubMed     Abstract available


  71. GREYLING T, Rossouw S
    Positive attitudes towards COVID-19 vaccines: A cross-country analysis.
    PLoS One. 2022;17:e0264994.
    PubMed     Abstract available


  72. TOLOSSA T, Wakuma B, Turi E, Mulisa D, et al
    Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey.
    PLoS One. 2022;17:e0265061.
    PubMed     Abstract available


  73. KUGELER KJ, Williamson J, Curns AT, Healy JM, et al
    Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States-January-July, 2021.
    PLoS One. 2022;17:e0264179.
    PubMed     Abstract available


  74. ORTIZ-PAREDES D, Varsaneux O, Worthington J, Park H, et al
    Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons.
    PLoS One. 2022;17:e0264145.
    PubMed     Abstract available


  75. TZOU PL, Tao K, Pond SLK, Shafer RW, et al
    Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons.
    PLoS One. 2022;17:e0261045.
    PubMed     Abstract available


  76. ROCHA FILHO TM, Mendes JFF, Murari TB, Nascimento Filho AS, et al
    Optimization of COVID-19 vaccination and the role of individuals with a high number of contacts: A model based approach.
    PLoS One. 2022;17:e0262433.
    PubMed     Abstract available


  77. HABIBZADEH F, Chumakov K, Sajadi MM, Yadollahie M, et al
    Use of oral polio vaccine and the incidence of COVID-19 in the world.
    PLoS One. 2022;17:e0265562.
    PubMed     Abstract available


  78. XIAO S, Nayak B, Samuel A, Paldurai A, et al
    Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain.
    PLoS One. 2022;17:e0265578.
    PubMed     Abstract available


  79. HAMILTON K, Hagger MS
    The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation.
    PLoS One. 2022;17:e0264784.
    PubMed     Abstract available


  80. BEG BM, Hussain T, Ahmad M, Areej S, et al
    Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan.
    PLoS One. 2022;17:e0266028.
    PubMed     Abstract available


  81. REINHARDT B, Taylor R, Dawkins C, Banks T, et al
    The use of dried blood spot cards to assess serologic responses of individuals vaccinated against measles, hepatitis A, tetanus, influenza and varicella zoster.
    PLoS One. 2022;17:e0265813.
    PubMed     Abstract available


  82. SAJID M, Marriam S, Mukhtar H, Sohail S, et al
    Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2.
    PLoS One. 2022;17:e0264700.
    PubMed     Abstract available


  83. ROY DN, Biswas M, Islam E, Azam MS, et al
    Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review.
    PLoS One. 2022;17:e0265496.
    PubMed     Abstract available


  84. DHAOUADI S, Kharroubi G, Cherif A, Cherif I, et al
    Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia.
    PLoS One. 2022;17:e0265390.
    PubMed     Abstract available


  85. SPRENGER R, Hackl D, Kossack N, Schiffner-Rohe J, et al
    Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
    PLoS One. 2022;17:e0265433.
    PubMed     Abstract available


  86. PURSELL T, Spencer Clinton JL, Tan J, Peng R, et al
    Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.
    PLoS One. 2022;17:e0265424.
    PubMed     Abstract available


  87. HIMBERT S, Gastaldo IP, Ahmed R, Pomier KM, et al
    Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes.
    PLoS One. 2022;17:e0263671.
    PubMed     Abstract available


  88. HARTMANN W, Brunn ML, Stetter N, Gabriel G, et al
    Pre-existing helminth infection impairs the efficacy of adjuvanted influenza vaccination in mice.
    PLoS One. 2022;17:e0266456.
    PubMed     Abstract available


  89. CHRISTODOULOU J, Fehrenbacher AE, Shaw EH, Vincent EM, et al
    COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV.
    PLoS One. 2022;17:e0266321.
    PubMed     Abstract available


  90. NEWMAN PA, Reid L, Tepjan S, Fantus S, et al
    COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review.
    PLoS One. 2022;17:e0266120.
    PubMed     Abstract available


  91. AL-DAHSHAN A, Selim N, Al-Kubaisi N, Mahfoud Z, et al
    Primary care physicians' knowledge of travel vaccine and malaria chemoprophylaxis and associated predictors in Qatar.
    PLoS One. 2022;17:e0265953.
    PubMed     Abstract available


  92. KREPS S, Kriner DL
    Communication about vaccine efficacy and COVID-19 vaccine choice: Evidence from a survey experiment in the United States.
    PLoS One. 2022;17:e0265011.
    PubMed     Abstract available


  93. THIRUMURTHY H, Milkman KL, Volpp KG, Buttenheim AM, et al
    Association between statewide financial incentive programs and COVID-19 vaccination rates.
    PLoS One. 2022;17:e0263425.
    PubMed     Abstract available


  94. NOURANI L, Abouie Mehrizi A, Zakeri S, Djadid ND, et al
    Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.
    PLoS One. 2022;17:e0266067.
    PubMed     Abstract available


  95. HAJEK A, Konig HH
    Level and correlates of empathy and altruism during the Covid-19 pandemic. Evidence from a representative survey in Germany.
    PLoS One. 2022;17:e0265544.
    PubMed     Abstract available


  96. GRASO M
    The new normal: Covid-19 risk perceptions and support for continuing restrictions past vaccinations.
    PLoS One. 2022;17:e0266602.
    PubMed     Abstract available


  97. YACOUTI A, Elkhoudri N, El Got A, Benider A, et al
    Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.
    PLoS One. 2022;17:e0266081.
    PubMed     Abstract available


  98. RAJA SM, Osman ME, Musa AO, Hussien AA, et al
    COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan.
    PLoS One. 2022;17:e0266670.
    PubMed     Abstract available


  99. FISKE A, Schonweitz F, Eichinger J, Zimmermann B, et al
    The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.
    PLoS One. 2022;17:e0266659.
    PubMed     Abstract available


  100. HASSOUNEH L, Dunsiger S
    The impact of mental distress on influenza vaccine coverage.
    PLoS One. 2022;17:e0266692.
    PubMed     Abstract available


  101. KAINE G, Wright V, Greenhalgh S
    Predicting willingness to be vaccinated for Covid-19: Evidence from New Zealand.
    PLoS One. 2022;17:e0266485.
    PubMed     Abstract available


  102. OCHWEDO KO, Onyango SA, Omondi CJ, Orondo PW, et al
    Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.
    PLoS One. 2022;17:e0266394.
    PubMed     Abstract available


  103. NAVAZI F, Yuan Y, Archer N
    The effect of the Ontario stay-at-home order on Covid-19 third wave infections including vaccination considerations: An interrupted time series analysis.
    PLoS One. 2022;17:e0265549.
    PubMed     Abstract available


  104. JENSEN UT, Ayers S, Koskan AM
    Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions.
    PLoS One. 2022;17:e0265736.
    PubMed     Abstract available


  105. REN Z, Nishimura M, Tjan LH, Furukawa K, et al
    Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak.
    PLoS One. 2022;17:e0266270.
    PubMed     Abstract available


  106. SHARMA R, Anand A
    The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines.
    PLoS One. 2022;17:e0266271.
    PubMed     Abstract available


  107. ALHATIM N, Al-Bashaireh AM, Alqudah O
    Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia.
    PLoS One. 2022;17:e0266440.
    PubMed     Abstract available


  108. KIHL P, Krych L, Deng L, Hansen LH, et al
    Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination.
    PLoS One. 2022;17:e0266719.
    PubMed     Abstract available


  109. MEYERHARDT JA, Yue H, Nowak RP, Brais L, et al
    Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
    PLoS One. 2022;17:e0266791.
    PubMed     Abstract available


  110. RAHIMI BA, Ishaq N, Mudaser GM, Taylor WR, et al
    Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.
    PLoS One. 2022;17:e0265487.
    PubMed     Abstract available


  111. SEDEGAH M, Porter C, Hollingdale MR, Ganeshan H, et al
    CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
    PLoS One. 2022;17:e0266691.
    PubMed     Abstract available


  112. SARGENT RH, Laurie S, Moncada L, Weakland LF, et al
    Masks, money, and mandates: A national survey on efforts to increase COVID-19 vaccination intentions in the United States.
    PLoS One. 2022;17:e0267154.
    PubMed     Abstract available


  113. SAITO Y
    The role of vaccination in a model of asset pricing during a pandemic.
    PLoS One. 2022;17:e0266511.
    PubMed     Abstract available


  114. RABIL MJ, Tunc S, Bish DR, Bish EK, et al
    Benefits of integrated screening and vaccination for infection control.
    PLoS One. 2022;17:e0267388.
    PubMed     Abstract available


  115. MUNDAGOWA PT, Tozivepi SN, Chiyaka ET, Mukora-Mutseyekwa F, et al
    Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey.
    PLoS One. 2022;17:e0266724.
    PubMed     Abstract available


  116. BARMPOUNAKIS P, Demiris N, Kontoyiannis I, Pavlakis GN, et al
    Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece.
    PLoS One. 2022;17:e0263977.
    PubMed     Abstract available


  117. SHUKLA A, Welch K, Villa A
    Assessment of the willingness of dentists in the state of Indiana to administer vaccines.
    PLoS One. 2022;17:e0267167.
    PubMed     Abstract available


  118. LIN GSS, Lee HY, Leong JZ, Sulaiman MM, et al
    COVID-19 vaccination acceptance among dental students and dental practitioners: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267354.
    PubMed     Abstract available


  119. ABED ELHADI SHAHBARI N, Gesser-Edelsburg A, Davidovitch N, Brammli-Greenberg S, et al
    Risk perceptions regarding inclusion of seasonal influenza vaccinations in the school immunization program in Israel: Arab vs. Jewish mothers.
    PLoS One. 2022;17:e0267279.
    PubMed     Abstract available


  120. CHAM J, Pandey AC, New J, Huynh T, et al
    6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    PLoS One. 2022;17:e0266781.
    PubMed     Abstract available


  121. GAULTIER GN, Nix EB, Thorgrimson J, Boreham D, et al
    Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults.
    PLoS One. 2022;17:e0267051.
    PubMed     Abstract available


  122. ANASTASSOPOULOU C, Antoni D, Manoussopoulos Y, Stefanou P, et al
    Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods.
    PLoS One. 2022;17:e0266958.
    PubMed     Abstract available


  123. JIAMSIRI S, Rhee C, Ahn HS, Poudyal N, et al
    A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand.
    PLoS One. 2022;17:e0267294.
    PubMed     Abstract available


  124. BUCZEL M, Szyszka PD, Siwiak A, Szpitalak M, et al
    Vaccination against misinformation: The inoculation technique reduces the continued influence effect.
    PLoS One. 2022;17:e0267463.
    PubMed     Abstract available


  125. RIGHOLT CH, Willows K, Kliewer EV, Mahmud SM, et al
    Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
    PLoS One. 2022;17:e0267646.
    PubMed     Abstract available


  126. WIGGEN TD, Bohn B, Ulrich AK, Stovitz SD, et al
    SARS-CoV-2 seroprevalence among healthcare workers.
    PLoS One. 2022;17:e0266410.
    PubMed     Abstract available


  127. RICHARDSON JR, Gotz R, Mayr V, Lohse MJ, et al
    SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
    PLoS One. 2022;17:e0266701.
    PubMed     Abstract available


  128. CHANSAENROJ J, Yorsaeng R, Puenpa J, Wanlapakorn N, et al
    Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    PLoS One. 2022;17:e0267102.
    PubMed     Abstract available


  129. MBULAWA ZZA, Phohlo K, Garcia-Jardon M, Williamson AL, et al
    High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
    PLoS One. 2022;17:e0264498.
    PubMed     Abstract available


  130. HONG H, Malfeld S, Smit S, Makhathini L, et al
    A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine.
    PLoS One. 2022;17:e0265870.
    PubMed     Abstract available


  131. ASSI S, Arafat B, Abbas I, Evans K, et al
    Evaluation of portable near-infrared spectroscopy for authentication of mRNA based COVID-19 vaccines.
    PLoS One. 2022;17:e0267214.
    PubMed     Abstract available


  132. STOCKLI S, Spalti AK, Phillips J, Stoeckel F, et al
    Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment.
    PLoS One. 2022;17:e0266003.
    PubMed     Abstract available


  133. DONG L, Bogart LM, Gandhi P, Aboagye JB, et al
    A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake.
    PLoS One. 2022;17:e0268020.
    PubMed     Abstract available


  134. BICHER M, Rippinger C, Zechmeister M, Jahn B, et al
    An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply.
    PLoS One. 2022;17:e0265957.
    PubMed     Abstract available


  135. FLOREA A, Sy LS, Luo Y, Qian L, et al
    Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study.
    PLoS One. 2022;17:e0267824.
    PubMed     Abstract available


  136. STOTO MA, Schlageter S, Kraemer JD
    COVID-19 mortality in the United States: It's been two Americas from the start.
    PLoS One. 2022;17:e0265053.
    PubMed     Abstract available


  137. HONSKUS M, Okonji Z, Musilek M, Krizova P, et al
    Whole genome sequencing of Neisseria meningitidis Y isolates collected in the Czech Republic in 1993-2018.
    PLoS One. 2022;17:e0265066.
    PubMed     Abstract available


  138. OLU-ABIODUN O, Abiodun O, Okafor N
    COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors.
    PLoS One. 2022;17:e0267691.
    PubMed     Abstract available


  139. FREUND O, Tau L, Weiss TE, Zornitzki L, et al
    Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era.
    PLoS One. 2022;17:e0268050.
    PubMed     Abstract available


  140. FARIA DE CARVALHO R, de Siqueira Penna Quintaes L, de Cassia de Souza Su T, Mitiko Kobayashi L, et al
    Short communication: Feasibility of dengue vaccine to infect different human cell lines: An alternative potency test using HEK293T cells.
    PLoS One. 2022;17:e0267653.
    PubMed     Abstract available


  141. HIJANO DR, Hoffman JM, Tang L, Schultz-Cherry SL, et al
    An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic.
    PLoS One. 2022;17:e0268237.
    PubMed     Abstract available


  142. OKUNLOLA OA, Oyeyemi OT
    Malaria transmission in Africa: Its relationship with yellow fever and measles.
    PLoS One. 2022;17:e0268080.
    PubMed     Abstract available


  143. MURUGESAN M, Mathews P, Paul H, Karthik R, et al
    Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India.
    PLoS One. 2022;17:e0268797.
    PubMed     Abstract available


  144. SSEKAMATTE T, Isunju JB, Mutyoba JN, Tetui M, et al
    Predictors of Hepatitis B screening and vaccination status of young psychoactive substance users in informal settlements in Kampala, Uganda.
    PLoS One. 2022;17:e0267953.
    PubMed     Abstract available


  145. DAZA-TORRES ML, Garcia YE, Schmidt AJ, Pollock BH, et al
    The impact of COVID-19 vaccination on California's return to normalcy.
    PLoS One. 2022;17:e0264195.
    PubMed     Abstract available


  146. OSUJI VC, Galante EM, Mischoulon D, Slaven JE, et al
    COVID-19 vaccine: A 2021 analysis of perceptions on vaccine safety and promise in a U.S. sample.
    PLoS One. 2022;17:e0268784.
    PubMed     Abstract available


  147. BONNER KE, Ssekyanzi H, Sicsic J, Mueller JE, et al
    What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda.
    PLoS One. 2022;17:e0268063.
    PubMed     Abstract available


  148. WITUS LS, Larson E
    A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention.
    PLoS One. 2022;17:e0267580.
    PubMed     Abstract available


  149. GUZMAN-HOLST A, Luna-Casas G, Burguete Garcia A, Madrid-Marina V, et al
    Burden of disease and associated complications of hepatitis a in children and adults in Mexico: A retrospective database study.
    PLoS One. 2022;17:e0268469.
    PubMed     Abstract available


  150. ACKAH M, Ameyaw L, Gazali Salifu M, Afi Asubonteng DP, et al
    COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268711.
    PubMed     Abstract available


  151. IWAMOTO M, Ukimura A, Ogawa T, Kawanishi F, et al
    Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study.
    PLoS One. 2022;17:e0268529.
    PubMed     Abstract available


  152. EL DEEB O, Jalloul M
    Efficacy versus abundancy: Comparing vaccination schemes.
    PLoS One. 2022;17:e0267840.
    PubMed     Abstract available


  153. WINARTO H, Habiburrahman M, Dorothea M, Wijaya A, et al
    Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.
    PLoS One. 2022;17:e0266139.
    PubMed     Abstract available


  154. SEREDA AD, Kazakova AS, Dmitrenko VV, Kolbasov DV, et al
    Search for additional tests for immunobiological evaluation of the candidate vaccines against African swine fever.
    PLoS One. 2022;17:e0265819.
    PubMed     Abstract available


  155. MERMIN-BUNNELL K, Ahn WK
    It's Time to be disgusting about COVID-19: Effect of disgust priming on COVID-19 public health compliance among liberals and conservatives.
    PLoS One. 2022;17:e0267735.
    PubMed     Abstract available


  156. BUTLER JZ, Carson M, Rios-Fetchko F, Vargas R, et al
    COVID-19 vaccination readiness among multiple racial and ethnic groups in the San Francisco Bay Area: A qualitative analysis.
    PLoS One. 2022;17:e0266397.
    PubMed     Abstract available


  157. ASRI A, Asri V, Renerte B, Follmi-Heusi F, et al
    Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals.
    PLoS One. 2022;17:e0268775.
    PubMed     Abstract available


  158. AHETO JMK, Pannell O, Dotse-Gborgbortsi W, Trimner MK, et al
    Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria.
    PLoS One. 2022;17:e0269066.
    PubMed     Abstract available


  159. SPRENGHOLZ P, Henkel L, Betsch C
    Payments and freedoms: Effects of monetary and legal incentives on COVID-19 vaccination intentions in Germany.
    PLoS One. 2022;17:e0268911.
    PubMed     Abstract available


  160. SILVA EKVB, Bomfim CG, Barbosa AP, Noda P, et al
    Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.
    PLoS One. 2022;17:e0268434.
    PubMed     Abstract available


  161. RAQIB R, Sarker P, Akhtar E, Nurul Huda TM, et al
    Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    PLoS One. 2022;17:e0268093.
    PubMed     Abstract available


  162. NG JWJ, Vaithilingam S, Nair M, Hwang LA, et al
    Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework.
    PLoS One. 2022;17:e0268926.
    PubMed     Abstract available


  163. NISHIMURA M, Sugawa S, Ota S, Suematsu E, et al
    Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
    PLoS One. 2022;17:e0267566.
    PubMed     Abstract available


  164. AGHAMIR SMK, Khatami F, Farrokhpour H, Oliveira Reis L, et al
    Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis.
    PLoS One. 2022;17:e0267934.
    PubMed     Abstract available


  165. GEBRETNSAE H, Hadgu T, Ayele B, Gebre-Egziabher E, et al
    Knowledge of vaccine handlers and status of cold chain and vaccine management in primary health care facilities of Tigray region, Northern Ethiopia: Institutional based cross-sectional study.
    PLoS One. 2022;17:e0269183.
    PubMed     Abstract available


  166. ROGERS BG, Tao J, Almonte A, Toma E, et al
    Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island.
    PLoS One. 2022;17:e0268587.
    PubMed     Abstract available


  167. PILTCH-LOEB R, Silver DR, Kim Y, Norris H, et al
    Determinants of the COVID-19 vaccine hesitancy spectrum.
    PLoS One. 2022;17:e0267734.
    PubMed     Abstract available


  168. AHIAKPA JK, Cosmas NT, Anyiam FE, Enalume KO, et al
    COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans.
    PLoS One. 2022;17:e0268230.
    PubMed     Abstract available


  169. JOSHI A, Surapaneni KM, Kaur M, Bhatt A, et al
    A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    PLoS One. 2022;17:e0269299.
    PubMed     Abstract available


  170. PATRICK L, Bakeera-Kitaka S, Rujumba J, Malande OO, et al
    Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.
    PLoS One. 2022;17:e0269655.
    PubMed     Abstract available


  171. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed     Abstract available


  172. ERCHICK DJ, Gupta M, Blunt M, Bansal A, et al
    Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders.
    PLoS One. 2022;17:e0269606.
    PubMed     Abstract available


  173. KHAIRKHAH N, Bolhassani A, Agi E, Namvar A, et al
    Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen.
    PLoS One. 2022;17:e0268251.
    PubMed     Abstract available


  174. BITZENHOFER M, Suter-Riniker F, Moor MB, Sidler D, et al
    Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.
    PLoS One. 2022;17:e0268780.
    PubMed     Abstract available


  175. DARKWA S, de Wildt G, Dalaba M, Vidzro E, et al
    "I would have to sell things in order to get the money": A qualitative exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta region, Ghana.
    PLoS One. 2022;17:e0268009.
    PubMed     Abstract available


  176. VILLANUEVA P, Wadia U, Crawford NW, Messina NL, et al
    The safety of co-administration of Bacille Calmette-Guerin (BCG) and influenza vaccines.
    PLoS One. 2022;17:e0268042.
    PubMed     Abstract available


  177. MOSE A, Wasie A, Shitu S, Haile K, et al
    Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269273.
    PubMed     Abstract available


  178. DE ANDRADE PEREIRA SILVA M, Ribeiro HF, Oliveira RR, Pelloso FC, et al
    Factors associated with vaccination against Covid-19 in pregnant and hospitalized postpartum women: A retrospective cohort study.
    PLoS One. 2022;17:e0269091.
    PubMed     Abstract available


  179. BOHN-GOLDBAUM E, Owen KB, Lee VYJ, Booy R, et al
    Physical activity and acute exercise benefit influenza vaccination response: A systematic review with individual participant data meta-analysis.
    PLoS One. 2022;17:e0268625.
    PubMed     Abstract available


  180. GU M, Taylor B, Pollack HA, Schneider JA, et al
    A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US.
    PLoS One. 2022;17:e0269320.
    PubMed     Abstract available


  181. RANI MDM, Mohamed NA, Solehan HM, Ithnin M, et al
    Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach.
    PLoS One. 2022;17:e0269059.
    PubMed     Abstract available


  182. PAPANEOPHYTOU C, Nicolaou A, Pieri M, Nicolaidou V, et al
    Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.
    PLoS One. 2022;17:e0269885.
    PubMed     Abstract available


  183. RANGELOVA V, Raycheva R, Sariyan S, Kevorkyan A, et al
    Reporting adverse events of COVID-19 vaccines: The case of Bulgaria.
    PLoS One. 2022;17:e0269727.
    PubMed     Abstract available


  184. KOBASHI Y, Shimazu Y, Kawamura T, Nishikawa Y, et al
    Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
    PLoS One. 2022;17:e0269917.
    PubMed     Abstract available


  185. PAWASKAR M, Fergie J, Harley C, Samant S, et al
    Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.
    PLoS One. 2022;17:e0269916.
    PubMed     Abstract available


  186. MA Y, Zhao Y, Chen R, Sun W, et al
    Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice.
    PLoS One. 2022;17:e0269153.
    PubMed     Abstract available


  187. DESALEGN M, Garoma G, Tamrat H, Desta A, et al
    The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    PLoS One. 2022;17:e0265140.
    PubMed     Abstract available


  188. CERVANTES-LUEVANO K, Espino-Vazquez AN, Flores-Acosta G, Bernaldez-Sarabia J, et al
    Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.
    PLoS One. 2022;17:e0269032.
    PubMed     Abstract available


  189. SIEWCHAISAKUL P, Sarakarn P, Nanthanangkul S, Longkul J, et al
    Role of literacy, fear and hesitancy on acceptance of COVID-19 vaccine among village health volunteers in Thailand.
    PLoS One. 2022;17:e0270023.
    PubMed     Abstract available


  190. MOONEY J, Price J, Bain C, Bawa JT, et al
    Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries.
    PLoS One. 2022;17:e0270369.
    PubMed     Abstract available


  191. LANIER HD, Diaz MI, Saleh SN, Lehmann CU, et al
    Analyzing COVID-19 disinformation on Twitter using the hashtags #scamdemic and #plandemic: Retrospective study.
    PLoS One. 2022;17:e0268409.
    PubMed     Abstract available


  192. BACURAU AGM, Sato APS, Francisco PMSB
    Correction: Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2022;17:e0270443.
    PubMed     Abstract available


  193. TAKEUCHI M, Esaki A, Higa Y, Nakazono A, et al
    Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination?
    PLoS One. 2022;17:e0263486.
    PubMed     Abstract available


  194. ACHENBACH CJ, Caputo M, Hawkins C, Balmert LC, et al
    Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.
    PLoS One. 2022;17:e0270060.
    PubMed     Abstract available


  195. ABAY ES, Belew MD, Ketsela BS, Mengistu EE, et al
    Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0269923.
    PubMed     Abstract available


  196. AWUNI JA, Ayamga M, Dagunga G
    Covid-19 vaccination intensions among literate Ghanaians: Still the need to dissipate fear and build trust on vaccine efficacy?
    PLoS One. 2022;17:e0270742.
    PubMed     Abstract available


  197. SAAD E, Sadiq S, Jamil R, Rustam F, et al
    Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data.
    PLoS One. 2022;17:e0270327.
    PubMed     Abstract available


  198. BURGER MN, Mayer M, Steimanis I
    Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany.
    PLoS One. 2022;17:e0270666.
    PubMed     Abstract available


  199. RAHMAN MM, Chisty MA, Alam MA, Sakib MS, et al
    Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh.
    PLoS One. 2022;17:e0270684.
    PubMed     Abstract available


  200. AMOUR MA, Rees CA, Munseri PJ, Said J, et al
    Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    PLoS One. 2022;17:e0268685.
    PubMed     Abstract available


  201. FERGIE J, Pawaskar M, Veeranki P, Samant S, et al
    Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US.
    PLoS One. 2022;17:e0269596.
    PubMed     Abstract available


  202. ATSAWASUWAN P, Del Campo DM, Del Campo LM, Viana G, et al
    Positivity rates of SAR-CoV-2 infection in orthodontic patients at the orthodontic clinic, University of Illinois Chicago.
    PLoS One. 2022;17:e0270311.
    PubMed     Abstract available


  203. PRAKASH A, Jeyakumar Nathan R, Kini S, Victor V, et al
    Message framing and COVID-19 vaccine acceptance among millennials in South India.
    PLoS One. 2022;17:e0269487.
    PubMed     Abstract available


  204. OKAI GA, Abekah-Nkrumah G
    The level and determinants of COVID-19 vaccine acceptance in Ghana.
    PLoS One. 2022;17:e0270768.
    PubMed     Abstract available


  205. MAGEE L, Knights F, Mckechnie DGJ, Al-Bedaery R, et al
    Facilitators and barriers to COVID-19 vaccination uptake among ethnic minorities: A qualitative study in primary care.
    PLoS One. 2022;17:e0270504.
    PubMed     Abstract available


  206. JAFAR A, Dambul R, Dollah R, Sakke N, et al
    COVID-19 vaccine hesitancy in Malaysia: Exploring factors and identifying highly vulnerable groups.
    PLoS One. 2022;17:e0270868.
    PubMed     Abstract available


  207. FIERRO A, Romano S, Liccardo A
    Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.
    PLoS One. 2022;17:e0265159.
    PubMed     Abstract available


  208. BEREC L, Smid M, Pribylova L, Majek O, et al
    Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia.
    PLoS One. 2022;17:e0270801.
    PubMed     Abstract available


  209. BAIDEN F, Fleck S, Leigh B, Ayieko P, et al
    Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.
    PLoS One. 2022;17:e0270968.
    PubMed     Abstract available


  210. WANG J, Xu Z, Gao Q
    Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020.
    PLoS One. 2022;17:e0270630.
    PubMed     Abstract available


  211. ABO SHAMA NM, Mahmoud SH, Bagato O, AbdElsalam ET, et al
    Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study.
    PLoS One. 2022;17:e0269321.
    PubMed     Abstract available


  212. DROPKIN G
    Variation in COVID-19 booster uptake in England: An ecological study.
    PLoS One. 2022;17:e0270624.
    PubMed     Abstract available


  213. KUMAR CK, Balasubramanian R, Ongarello S, Carmona S, et al
    SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations.
    PLoS One. 2022;17:e0271103.
    PubMed     Abstract available


  214. BEYEN MW, Bulto GA, Chaka EE, Debelo BT, et al
    Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    PLoS One. 2022;17:e0271237.
    PubMed     Abstract available


  215. TEGEGNE MD, Girma S, Mengistu S, Mesfin T, et al
    Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia.
    PLoS One. 2022;17:e0269942.
    PubMed     Abstract available


  216. KONISHI T
    Mutations in SARS-CoV-2 are on the increase against the acquired immunity.
    PLoS One. 2022;17:e0271305.
    PubMed     Abstract available


  217. EL MANSOURI N, Ferrera L, Kharbach A, Achbani A, et al
    Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study.
    PLoS One. 2022;17:e0271222.
    PubMed     Abstract available


  218. SEREDA AD, Kazakova AS, Namsrayn SG, Vlasov ME, et al
    The attenuated ASFV strains MK-200 and FK-32/135 as possible models for investigation of protective immunity by ASFV infection.
    PLoS One. 2022;17:e0270641.
    PubMed     Abstract available


  219. GUJJULA KR, Gong J, Segundo B, Ntaimo L, et al
    COVID-19 vaccination policies under uncertain transmission characteristics using stochastic programming.
    PLoS One. 2022;17:e0270524.
    PubMed     Abstract available


  220. LIU B, Zhang M, Li X, Liu L, et al
    Influence of epidemic situation on COVID-19 vaccination between urban and rural residents in China-Vietnam border area: A cross-sectional survey.
    PLoS One. 2022;17:e0270345.
    PubMed     Abstract available


  221. HERMAN B, Wong MC, Viwattanakulvanid P
    Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study.
    PLoS One. 2022;17:e0271385.
    PubMed     Abstract available


  222. SIEGERS KE, van Herwaarden AE, de Waard JH, Del Nogal B, et al
    The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children.
    PLoS One. 2022;17:e0270736.
    PubMed     Abstract available


  223. HANSON CK, Liu K
    Think about your friends and family: The disparate impacts of relationship-centered messages on privacy concerns, protective health behavior, and vaccination against Covid-19.
    PLoS One. 2022;17:e0270279.
    PubMed     Abstract available


  224. JUNGE M, Li S, Samaranayake S, Zalesak M, et al
    Safe reopening of university campuses is possible with COVID-19 vaccination.
    PLoS One. 2022;17:e0270106.
    PubMed     Abstract available


  225. ZHANG A, Li D, Song C, Jing H, et al
    Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck.
    PLoS One. 2022;17:e0271746.
    PubMed     Abstract available


  226. ABUHAMMAD S, Khabour OF, Alzoubi KH, Hamaideh S, et al
    The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan.
    PLoS One. 2022;17:e0271625.
    PubMed     Abstract available


  227. FATIMA S, Zafar A, Afzal H, Ejaz T, et al
    COVID-19 infection among vaccinated and unvaccinated: Does it make any difference?
    PLoS One. 2022;17:e0270485.
    PubMed     Abstract available


  228. ABD EL FADEEL MR, Soliman EM, Allam AM, ElKersh MF, et al
    Efficacy and durability of bovine virus diarrhea (BVD) virus killed vaccine adjuvanted with monolaurin.
    PLoS One. 2022;17:e0269031.
    PubMed     Abstract available


  229. TRAJMAN A, Lachapelle-Chisholm S, Zikos T, Werneck GL, et al
    Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0265414.
    PubMed     Abstract available


  230. KADYROVA I, Yegorov S, Negmetzhanov B, Kolesnikova Y, et al
    High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
    PLoS One. 2022;17:e0272008.
    PubMed     Abstract available


  231. HWANG J, Su MH, Jiang X, Lian R, et al
    Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy.
    PLoS One. 2022;17:e0271394.
    PubMed     Abstract available


  232. GOTO T, Tani N, Ikematsu H, Gondo K, et al
    Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
    PLoS One. 2022;17:e0272056.
    PubMed     Abstract available


  233. KHOKHAR F, Pickard D, Dyson Z, Iqbal J, et al
    Multiplex PCR assay to detect high risk lineages of Salmonella Typhi and Paratyphi A.
    PLoS One. 2022;17:e0267805.
    PubMed     Abstract available


  234. AL-OBAYDI S, Hennrikus E, Mohammad N, Lehman EB, et al
    Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
    PLoS One. 2022;17:e0272691.
    PubMed     Abstract available


  235. THORPE A, Fagerlin A, Butler J, Stevens V, et al
    Communicating about COVID-19 vaccine development and safety.
    PLoS One. 2022;17:e0272426.
    PubMed     Abstract available


  236. FACCIN M, Gargiulo F, Atlani-Duault L, Ward JK, et al
    Assessing the influence of French vaccine critics during the two first years of the COVID-19 pandemic.
    PLoS One. 2022;17:e0271157.
    PubMed     Abstract available


  237. KAN Y, Asada M, Uesawa Y
    Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study.
    PLoS One. 2022;17:e0269268.
    PubMed     Abstract available


  238. SUMALI B, Mitsukura Y, Nishimura T
    Contactless continuous heart rate monitoring system using ballistocardiography.
    PLoS One. 2022;17:e0272072.
    PubMed     Abstract available


  239. OTUNUGA OM
    Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to COVID-19.
    PLoS One. 2022;17:e0271446.
    PubMed     Abstract available


  240. LEE HW, Leng CH, Chan TC
    Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan.
    PLoS One. 2022;17:e0270349.
    PubMed     Abstract available


  241. NAKAMANYA S, Kawuma R, Kibuuka D, Kusemererwa S, et al
    Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
    PLoS One. 2022;17:e0271104.
    PubMed     Abstract available


  242. SABZIAN-MOLAEI F, Nasiri Khalili MA, Sabzian-Molaei M, Shahsavarani H, et al
    Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection.
    PLoS One. 2022;17:e0268156.
    PubMed     Abstract available


  243. CHEN J, Chou SY, Yu TH, Rizqi ZU, et al
    System dynamics analysis on the effectiveness of vaccination and social mobilization policies for COVID-19 in the United States.
    PLoS One. 2022;17:e0268443.
    PubMed     Abstract available


  244. SHUI X, Wang F, Li L, Liang Q, et al
    COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0273112.
    PubMed     Abstract available


  245. HUIBERTS A, van Cleef B, Tjon-A-Tsien A, Dijkstra F, et al
    Influenza vaccination of school teachers: A scoping review and an impact estimation.
    PLoS One. 2022;17:e0272332.
    PubMed     Abstract available


  246. RAYAMAJHI S, Rafi MA, Tripathi N, Dongol AS, et al
    Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    PLoS One. 2022;17:e0272729.
    PubMed     Abstract available


  247. MEGHANI A, Agarwal S, Zapf AJ, Edwards JG, et al
    Schooling amidst a pandemic in the United States: Parents' perceptions about reopening schools and anticipated challenges during COVID-19.
    PLoS One. 2022;17:e0268427.
    PubMed     Abstract available


  248. NKA AD, Ka'e AC, Bouba Y, Ngoufack Jagni Semengue E, et al
    Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol.
    PLoS One. 2022;17:e0272839.
    PubMed     Abstract available


  249. ALSAGABY SA, Alharbi NK, Alhumaydhi FA, Alsubaie F, et al
    Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination.
    PLoS One. 2022;17:e0272869.
    PubMed     Abstract available


  250. AEMRO A, Fentie B, Wassie M
    Adherence to Covid-19 mitigation measures and its associated factors among health care workers at referral hospitals in Amhara regional state of Ethiopia.
    PLoS One. 2022;17:e0272570.
    PubMed     Abstract available


  251. SADEGHI K, Poorolajal J, Doosti-Irani A
    Prevalence of modifiable risk factors of tuberculosis and their population attributable fraction in Iran: A cross-sectional study.
    PLoS One. 2022;17:e0271511.
    PubMed     Abstract available


  252. SALVI N, Itta KC, Lachyan A, Hasan AZ, et al
    Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India.
    PLoS One. 2022;17:e0271920.
    PubMed     Abstract available


  253. RAYHAN MRI, Liza JM, Rahman MM
    Assessment of COVID-19 vaccination-related medical waste management practices in Bangladesh.
    PLoS One. 2022;17:e0273053.
    PubMed     Abstract available


  254. AFRIFA-ANANE GF, Larbi RT, Addo B, Agyekum MW, et al
    Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study.
    PLoS One. 2022;17:e0272876.
    PubMed     Abstract available


  255. HUSAIN F, Powys VR, White E, Jones R, et al
    COVID-19 vaccination uptake in 441 socially and ethnically diverse pregnant women.
    PLoS One. 2022;17:e0271834.
    PubMed     Abstract available


  256. LEONE V, Meisinger C, Temizel S, Kling E, et al
    Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
    PLoS One. 2022;17:e0272874.
    PubMed     Abstract available


  257. YAKUM MN, Funwie AD, Ajong AB, Tsafack M, et al
    Factors associated with routine vaccination card retention among children aged 0-59 months in Yaounde-Cameroon: A cross-sectional survey.
    PLoS One. 2022;17:e0273515.
    PubMed     Abstract available


  258. ZHANG M, Tian J, Li H, Cang M, et al
    The comparative genomic analysis provides insights into the phylogeny and virulence of tick-borne encephalitis virus vaccine strain Senzhang.
    PLoS One. 2022;17:e0273565.
    PubMed     Abstract available


  259. APIWATTANAKUL M, Suanprasert N, Rojana-Udomsart A, Termglinchan T, et al
    Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations.
    PLoS One. 2022;17:e0266118.
    PubMed     Abstract available


  260. KUMAR N, Sulaiman SAS, Hashmi FK, Qureshi A, et al
    Survey data of public in Sindh Pakistan regarding willingness to accept COVID-19 vaccination.
    PLoS One. 2022;17:e0270900.
    PubMed     Abstract available


  261. LUBEYA MK, Mwanahamuntu M, Chibwesha C, Mukosha M, et al
    Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2022;17:e0267617.
    PubMed     Abstract available


  262. SEN SR, Sanders EC, Santos AM, Bhuvan K, et al
    Evidence for deleterious effects of immunological history in SARS-CoV-2.
    PLoS One. 2022;17:e0272163.
    PubMed     Abstract available


  263. NUZHATH T, Hotez PJ, Damania A, Liu PS, et al
    Creation of a Global Vaccine Risk Index.
    PLoS One. 2022;17:e0272784.
    PubMed     Abstract available


  264. HERRMANN-WERNER A, Festl-Wietek T, Gille C, Zipfel S, et al
    Medical student attitudes on vaccination relevance: A mixed-method study.
    PLoS One. 2022;17:e0273529.
    PubMed     Abstract available


  265. OTENG AGYEMAN F, Ma Z, Li M, Kwasi Sampene A, et al
    Relevance of COVID-19 vaccine on the tourism industry: Evidence from China.
    PLoS One. 2022;17:e0269200.
    PubMed     Abstract available


  266. ASRATIE MH, Kassie BA, Belay DG, Endalew M, et al
    Perception of risk regarding the use of COVID-19 vaccine among pregnant women in Motta town and Hulet Eji Enese district, northwest Ethiopia.
    PLoS One. 2022;17:e0269591.
    PubMed     Abstract available


  267. DARWISH I, Harrison LB, Passos-Castilho AM, Labbe AC, et al
    In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada.
    PLoS One. 2022;17:e0272953.
    PubMed     Abstract available


  268. HOSSAIN MS, Islam MS, Pardhan S, Banik R, et al
    Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study.
    PLoS One. 2022;17:e0269944.
    PubMed     Abstract available


  269. CHOQUE-GUEVARA R, Poma-Acevedo A, Montesinos-Millan R, Rios-Matos D, et al
    Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models.
    PLoS One. 2022;17:e0269823.
    PubMed     Abstract available


  270. ROJAS CONVERSO T, Goulart C, Rodriguez D, Guerra MES, et al
    Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein.
    PLoS One. 2022;17:e0273017.
    PubMed     Abstract available


  271. STERNJAKOB-MARTHALER A, Berko-Gottel B, Rissland J, Schope J, et al
    Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates.
    PLoS One. 2022;17:e0273332.
    PubMed     Abstract available


  272. BURATTO A, Muttoni M, Wrzaczek S, Freiberger M, et al
    Should the COVID-19 lockdown be relaxed or intensified in case a vaccine becomes available?
    PLoS One. 2022;17:e0273557.
    PubMed     Abstract available


  273. JIANG F, Zhao Y, Bai J, Yang X, et al
    Perceived health literacy and COVID-19 vaccine acceptance among Chinese college students: A mediation analysis.
    PLoS One. 2022;17:e0273285.
    PubMed     Abstract available


  274. WASSERBAUER M, Hlava S, Trojanek M, Stovicek J, et al
    Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.
    PLoS One. 2022;17:e0273612.
    PubMed     Abstract available


  275. LEE KW, Gew LT, Siau CS, Peh SC, et al
    COVID-19 vaccine hesitancy and its associated factors in Malaysia.
    PLoS One. 2022;17:e0266925.
    PubMed     Abstract available


  276. WAGGLE KD, Griffith MP, Zhu L, Cooper VS, et al
    Genomic characterization of SARS-CoV-2 from vaccine breakthrough cases in Allegheny County, Pennsylvania.
    PLoS One. 2022;17:e0272954.
    PubMed     Abstract available


  277. BEHMARD E, Abdulabbas HT, Abdalkareem Jasim S, Najafipour S, et al
    Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach.
    PLoS One. 2022;17:e0272582.
    PubMed     Abstract available


  278. NASIRI O, Hajihassani M, Noori Goodarzi N, Fereshteh S, et al
    Reverse vaccinology approach to identify novel and immunogenic targets against Porphyromonas gingivalis: An in silico study.
    PLoS One. 2022;17:e0273770.
    PubMed     Abstract available


  279. SANNEH B, Sanneh S, Lareef-Jah S, Darboe B, et al
    Practice of preventive measures and vaccine hesitance for COVID 19 among households in The Gambia, 2021: Study protocol.
    PLoS One. 2022;17:e0270304.
    PubMed     Abstract available


  280. KYEI-ARTHUR F, Kyei-Gyamfi S, Agyekum MW, Afrifa-Anane GF, et al
    Parents' and guardians' acceptability of COVID-19 vaccination for children in Ghana: An online survey.
    PLoS One. 2022;17:e0272801.
    PubMed     Abstract available


  281. SCHNEPF J
    Does perceived scarcity of COVID-19 vaccines increase vaccination willingness? Results of an experimental study with German respondents in times of a national vaccine shortage.
    PLoS One. 2022;17:e0273441.
    PubMed     Abstract available


  282. SAELEE C, Hanthamrongwit J, Soe PT, Khaenam P, et al
    Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
    PLoS One. 2022;17:e0273517.
    PubMed     Abstract available


  283. HOANG PT, Luong QXT, Cho S, Lee Y, et al
    Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form.
    PLoS One. 2022;17:e0273934.
    PubMed     Abstract available


  284. GUNAWARDHANA N, Baecher K, Boutwell A, Pekwarake S, et al
    COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa.
    PLoS One. 2022;17:e0274541.
    PubMed     Abstract available


  285. MACHADO A, Kislaya I, Rodrigues AP, Sequeira D, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged >/=65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021
    PLoS One. 2022;17:e0274008.
    PubMed     Abstract available


  286. REBITSCHEK FG, Ellermann C, Jenny MA, Siegel NA, et al
    Fact boxes that inform individual decisions may contribute to a more positive evaluation of COVID-19 vaccinations at the population level.
    PLoS One. 2022;17:e0274186.
    PubMed     Abstract available


  287. DESANTIS SM, Leon-Novelo LG, Swartz MD, Yaseen AS, et al
    Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region.
    PLoS One. 2022;17:e0273694.
    PubMed     Abstract available


  288. SEMENZATO L, Botton J, Baricault B, Deloumeaux J, et al
    Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    PLoS One. 2022;17:e0274309.
    PubMed     Abstract available


  289. VALDES-DONOSO P, Jarvis LS
    Combining epidemiology and economics to assess control of a viral endemic animal disease: Porcine Reproductive and Respiratory Syndrome (PRRS).
    PLoS One. 2022;17:e0274382.
    PubMed     Abstract available


  290. GOGOI M, Wobi F, Qureshi I, Al-Oraibi A, et al
    "The vaccination is positive; I don't think it's the panacea": A qualitative study on COVID-19 vaccine attitudes among ethnically diverse healthcare workers in the United Kingdom.
    PLoS One. 2022;17:e0273687.
    PubMed     Abstract available


  291. ISMAIL N, Tavoschi L, Moazen B, Rosello A, et al
    COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review.
    PLoS One. 2022;17:e0267070.
    PubMed     Abstract available


  292. FULLER A, Hancox J, Vedhara K, Card T, et al
    Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.
    PLoS One. 2022;17:e0267769.
    PubMed     Abstract available


  293. YANG IN, Lu CL, Tang HJ, Kuo YC, et al
    Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.
    PLoS One. 2022;17:e0273676.
    PubMed     Abstract available


  294. HUHN G, Poorbaugh J, Zhang L, Beasley S, et al
    COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
    PLoS One. 2022;17:e0273323.
    PubMed     Abstract available


  295. MOON YJ, Cho KS, Jeong JY, Chung DY, et al
    Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations.
    PLoS One. 2022;17:e0273733.
    PubMed     Abstract available


  296. BENNETT NG, Bloom DE, Ferranna M
    Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption.
    PLoS One. 2022;17:e0274529.
    PubMed     Abstract available


  297. AGOSTI F, Toffolutti V, Cavalli N, Nivakoski S, et al
    Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries.
    PLoS One. 2022;17:e0273555.
    PubMed     Abstract available


  298. LIMAYE RJ, Balgobin K, Michel A, Schulz G, et al
    What message appeal and messenger are most persuasive for COVID-19 vaccine uptake: Results from a 5-country survey in India, Indonesia, Kenya, Nigeria, and Ukraine.
    PLoS One. 2022;17:e0274966.
    PubMed     Abstract available


  299. WU H, Xue M, Wu C, Lu Q, et al
    Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China.
    PLoS One. 2022;17:e0274421.
    PubMed     Abstract available


  300. LEDESMA JR, Lurie P, Yorlets RR, Daly G, et al
    Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
    PLoS One. 2022;17:e0274900.
    PubMed     Abstract available


  301. FRAUCHES TS, Costa CAS, Rodrigues CDS, de Azevedo MCVM, et al
    COVID-19 cross-sectional study in Marica, Brazil: The impact of vaccination coverage on viral incidence.
    PLoS One. 2022;17:e0269011.
    PubMed     Abstract available


  302. CAPPELLI L, Cinelli P, Giusti F, Ferlenghi I, et al
    Self-assembling protein nanoparticles and virus like particles correctly display beta-barrel from meningococcal factor H-binding protein through genetic fusion.
    PLoS One. 2022;17:e0273322.
    PubMed     Abstract available


  303. HEFELE L, Lai J, Vilivong K, Bounkhoun T, et al
    Haemophilus influenzae serotype b seroprevalence in central Lao PDR before and after vaccine introduction.
    PLoS One. 2022;17:e0274558.
    PubMed     Abstract available


  304. SERETI I, Shaw-Saliba K, Dodd LE, Dewar RL, et al
    Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
    PLoS One. 2022;17:e0273914.
    PubMed     Abstract available


  305. GRAVAGNA K, Wolfson C, Sulis G, Buchan SA, et al
    Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging.
    PLoS One. 2022;17:e0275135.
    PubMed     Abstract available


  306. DE BOER J, Saade U, Granjon E, Trouillet-Assant S, et al
    A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects.
    PLoS One. 2022;17:e0274553.
    PubMed     Abstract available


  307. DAS P, Igoe M, Lenhart S, Luong L, et al
    Geographic disparities and determinants of COVID-19 incidence risk in the greater St. Louis Area, Missouri (United States).
    PLoS One. 2022;17:e0274899.
    PubMed     Abstract available


  308. AZAMI M, Nasirkandy MP, Esmaeili Gouvarchin Ghaleh H, Ranjbar R, et al
    COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272273.
    PubMed     Abstract available


  309. FULLER S, Kazemian S, Algara C, Simmons DJ, et al
    Assessing the effectiveness of COVID-19 vaccine lotteries: A cross-state synthetic control methods approach.
    PLoS One. 2022;17:e0274374.
    PubMed     Abstract available


  310. ABDUL AZIZ NI, Flanders S, Nungsari M
    Social expectations and government incentives in Malaysia's COVID-19 vaccine uptake.
    PLoS One. 2022;17:e0275010.
    PubMed     Abstract available


  311. ALLEN JD, Priebe Rocha L, Rose R, Hoch A, et al
    Intention to obtain a COVID-19 vaccine among Brazilian immigrant women in the U.S.
    PLoS One. 2022;17:e0274912.
    PubMed     Abstract available


  312. NICHOL B, Simonetti V, McCready J, Steen M, et al
    Barriers and facilitators to vaccination for COVID-19, pertussis, and influenza during pregnancy: Protocol for an umbrella review.
    PLoS One. 2022;17:e0275105.
    PubMed     Abstract available


  313. BETOUKE ONGWE ME, Mouwenda YD, Stam KA, Kremsner PG, et al
    Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon.
    PLoS One. 2022;17:e0275013.
    PubMed     Abstract available


  314. YAKUBU AM, Aryee NA, Bonney EY, Kotey EN, et al
    Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017.
    PLoS One. 2022;17:e0271321.
    PubMed     Abstract available


  315. KALIFF M, Lillsunde Larsson G, Helenius G, Karlsson MG, et al
    Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Orebro, Sweden.
    PLoS One. 2022;17:e0274825.
    PubMed     Abstract available


  316. OKRUSZEK L, Piejka A, Banasik-Jemielniak N, Jemielniak D, et al
    Climate change, vaccines, GMO: The N400 effect as a marker of attitudes toward scientific issues.
    PLoS One. 2022;17:e0273346.
    PubMed     Abstract available


  317. BOCKSTAL V, Shukarev G, McLean C, Goldstein N, et al
    First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
    PLoS One. 2022;17:e0274906.
    PubMed     Abstract available


  318. LUN P, Gao J, Tang B, Yu CC, et al
    A social ecological approach to identify the barriers and facilitators to COVID-19 vaccination acceptance: A scoping review.
    PLoS One. 2022;17:e0272642.
    PubMed     Abstract available


  319. NIEMINEN H, Hakulinen T, Puumalainen T, Siren P, et al
    Time and labour costs of preventive health care, including vaccinations, in Finnish child health clinics.
    PLoS One. 2022;17:e0270835.
    PubMed     Abstract available


  320. PAUDEL YR, Du C, MacDonald SE
    The influence of place on COVID-19 vaccine coverage in Alberta: A multilevel analysis.
    PLoS One. 2022;17:e0276160.
    PubMed     Abstract available


  321. KAPAR B, Buigut S, Rana F
    Winners and losers from Pfizer and Biontech's vaccine announcement: Evidence from S&P 500 (Sub)sector indices.
    PLoS One. 2022;17:e0275773.
    PubMed     Abstract available


  322. SULIS G, Rodrigue V, Wolfson C, McMillan JM, et al
    Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA).
    PLoS One. 2022;17:e0275923.
    PubMed     Abstract available


  323. WANG B, Wu L, Hong X, Han Y, et al
    Risk perception and subsidy policy-based voluntary vaccination driven by multiple information sources.
    PLoS One. 2022;17:e0276177.
    PubMed     Abstract available


  324. STREETER AJ, Rodgers LR, Masoli J, Lin NX, et al
    Real-world effectiveness of pneumococcal vaccination in older adults: Cohort study using the UK Clinical Practice Research Datalink.
    PLoS One. 2022;17:e0275642.
    PubMed     Abstract available


  325. JEEWANDARA C, Aberathna IS, Dayarathna S, Nimasha T, et al
    Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.
    PLoS One. 2022;17:e0274845.
    PubMed     Abstract available


  326. BIKAAKO W, Kabahango P, Mugabi K, Yawe A, et al
    Breaking institutional barriers to enhance women's participation in and benefit from the Peste des Petits Ruminants and Newcastle Disease vaccine value chains for Sembabule district of Uganda.
    PLoS One. 2022;17:e0270518.
    PubMed     Abstract available


  327. HANDAYANI S, Rias YA, Kurniasari MD, Agustin R, et al
    Relationship of spirituality, health engagement, health belief and attitudes toward acceptance and willingness to pay for a COVID-19 vaccine.
    PLoS One. 2022;17:e0274972.
    PubMed     Abstract available


  328. PETROVIC V, Ristic M, Milosavljevic B, Djilas M, et al
    Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.
    PLoS One. 2022;17:e0274674.
    PubMed     Abstract available


  329. SALMON DA, Schuh HB, Sargent RH, Konja A, et al
    Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population.
    PLoS One. 2022;17:e0274443.
    PubMed     Abstract available


  330. BAEK K, Maharjan S, Akauliya M, Thapa B, et al
    Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.
    PLoS One. 2022;17:e0275722.
    PubMed     Abstract available


  331. ALMONGY HM, Almetwally EM, Haj Ahmad H, H Al-Nefaie A, et al
    Modeling of COVID-19 vaccination rate using odd Lomax inverted Nadarajah-Haghighi distribution.
    PLoS One. 2022;17:e0276181.
    PubMed     Abstract available


  332. MARTINELLI M, Veltri GA
    Shared understandings of vaccine hesitancy: How perceived risk and trust in vaccination frame individuals' vaccine acceptance.
    PLoS One. 2022;17:e0276519.
    PubMed     Abstract available


  333. PARKER SJ, DeLaroche AM, Hill AB, Arora R, et al
    Influenza vaccination coverage among an urban pediatric asthma population: Implications for population health.
    PLoS One. 2022;17:e0269415.
    PubMed     Abstract available


  334. TADROUS M, Chung H, Men S, Chu C, et al
    Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study.
    PLoS One. 2022;17:e0273903.
    PubMed     Abstract available


  335. NAKAMURA A, Kotaki T, Nagai Y, Takazawa S, et al
    Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.
    PLoS One. 2022;17:e0274829.
    PubMed     Abstract available


  336. AMIN MB, Roy N, Meem AE, Hossain E, et al
    Trends and determinants of taking tetanus toxoid vaccine among women during last pregnancy in Bangladesh: Country representative survey from 2006 to 2019.
    PLoS One. 2022;17:e0276417.
    PubMed     Abstract available


  337. DAHAL S, Pokhrel S, Mehta S, Karki S, et al
    Acceptance and hesitancy of COVID-19 vaccine among Nepalese population: A cross-sectional study.
    PLoS One. 2022;17:e0275922.
    PubMed     Abstract available


  338. NICKEL O, Rockstroh A, Wolf J, Landgraf S, et al
    Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2.
    PLoS One. 2022;17:e0263861.
    PubMed     Abstract available


  339. VANNI T, Thome BC, Sparrow E, Friede M, et al
    Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
    PLoS One. 2022;17:e0274943.
    PubMed     Abstract available


  340. ALMANSOUR A, Hussein SM, Felemban SG, Mahamid AW, et al
    Acceptance and hesitancy of parents to vaccinate children against coronavirus disease 2019 in Saudi Arabia.
    PLoS One. 2022;17:e0276183.
    PubMed     Abstract available


  341. SEDEGAH M, Porter C, Goguet E, Ganeshan H, et al
    Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
    PLoS One. 2022;17:e0276241.
    PubMed     Abstract available


  342. VARGAS-HERRERA N, Fernandez-Navarro M, Cabezudo NE, Soto-Becerra P, et al
    Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru.
    PLoS One. 2022;17:e0268419.
    PubMed     Abstract available


  343. GAUTAM US, Asrican R, Sempowski GD
    Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system.
    PLoS One. 2022;17:e0276130.
    PubMed     Abstract available


  344. CONTRACTOR A, Shivaprakash S, Tiwari A, Setia MS, et al
    Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin (R)) in healthcare workers in Mumbai, India: A retrospective cohort analysis.
    PLoS One. 2022;17:e0276759.
    PubMed     Abstract available


  345. ARUFFO E, Yuan P, Tan Y, Gatov E, et al
    Community structured model for vaccine strategies to control COVID19 spread: A mathematical study.
    PLoS One. 2022;17:e0258648.
    PubMed     Abstract available


  346. TOBOLOWSKY FA, Waltenburg MA, Moritz ED, Haile M, et al
    Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020April 2021.
    PLoS One. 2022;17:e0275718.
    PubMed     Abstract available


  347. ENDERS AM, Uscinski J, Klofstad C, Stoler J, et al
    On the relationship between conspiracy theory beliefs, misinformation, and vaccine hesitancy.
    PLoS One. 2022;17:e0276082.
    PubMed     Abstract available


  348. CHERENACK EM, Salazar AS, Nogueira NF, Raccamarich P, et al
    Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age.
    PLoS One. 2022;17:e0276131.
    PubMed     Abstract available


  349. TARIMO EAM, Ambikile J, Munseri P, Bakari M, et al
    Personal experiences following acquiring HIV infection while volunteering in Phase I/II HIV vaccine trials: A qualitative study from Tanzania.
    PLoS One. 2022;17:e0276404.
    PubMed     Abstract available


  350. KIM YR, Choi YJ, Min Y
    A model of COVID-19 pandemic with vaccines and mutant viruses.
    PLoS One. 2022;17:e0275851.
    PubMed     Abstract available


  351. GOULART ROSA R, Spinardi J, Allen KE, Manfio J, et al
    BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan.
    PLoS One. 2022;17:e0276384.
    PubMed     Abstract available


  352. GOMBE B, Streatfield C, Leal L, Opio S, et al
    Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
    PLoS One. 2022;17:e0275927.
    PubMed     Abstract available


  353. FERNANDEZ-SUAREZ A, Jimenez Coronado R, Clavijo Aroca C, Navarro Martin E, et al
    New insights into antibody levels against SARS-CoV-2 for healthcare personnel vaccinated with tozinameran (Comirnaty).
    PLoS One. 2022;17:e0276968.
    PubMed     Abstract available


  354. ABDELHAMID MHM, Almsellati IA, Annajar BB, Abdulhamid AH, et al
    Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study.
    PLoS One. 2022;17:e0276425.
    PubMed     Abstract available


  355. AYNALEM ZB, Bogale TW, Bantie GM, Ayalew AF, et al
    Factors associated with willingness to take COVID-19 vaccine among pregnant women at Gondar town, Northwest Ethiopia: A multicenter institution-based cross-sectional study.
    PLoS One. 2022;17:e0276763.
    PubMed     Abstract available


  356. GETACHEW D, Yosef T, Solomon N, Tesfaye M, et al
    Predictors of unwillingness to receive COVID -19 vaccines among Ethiopian Medical students.
    PLoS One. 2022;17:e0276857.
    PubMed     Abstract available


  357. GANESAN S, Acosta H, Brigolin C, Orange K, et al
    Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
    PLoS One. 2022;17:e0272594.
    PubMed     Abstract available


  358. KIM M, Kim JH, Jung YW, Seong SJ, et al
    Gynecologic problems and healthcare behavior by shift patterns in Korean nursing staff.
    PLoS One. 2022;17:e0276282.
    PubMed     Abstract available


  359. MAINA D, Omuse G, Ong'ete G, Mugaine P, et al
    Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    PLoS One. 2022;17:e0267619.
    PubMed     Abstract available


  360. SAKAMOTO M, Ishizuka R, Ozawa C, Fukuda Y, et al
    Health information and COVID-19 vaccination: Beliefs and attitudes among Japanese university students.
    PLoS One. 2022;17:e0277435.
    PubMed     Abstract available


  361. OTHMAN B, Barakat M, Omar A, Al-Rawashdeh A, et al
    Evaluation of hepatitis B knowledge, practices, and beliefs among the Jordanian population: A cross-sectional study.
    PLoS One. 2022;17:e0277186.
    PubMed     Abstract available


  362. OLUSANYA OA, White B, Malik F, Hester KA, et al
    Healthcare professionals' perceptions and recommendations regarding adolescent vaccinations in Georgia and Tennessee during the COVID-19 pandemic: A qualitative research.
    PLoS One. 2022;17:e0277748.
    PubMed     Abstract available


  363. DARWEESH O, Khatab N, Kheder R, Mohammed T, et al
    Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
    PLoS One. 2022;17:e0274526.
    PubMed     Abstract available


  364. HOY C, Wood T, Moscoe E
    Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
    PLoS One. 2022;17:e0277493.
    PubMed     Abstract available


  365. STRACQUALURSI L, Agati P
    Covid-19 vaccines in Italian public opinion: Identifying key issues using Twitter and Natural Language Processing.
    PLoS One. 2022;17:e0277394.
    PubMed     Abstract available


  366. NEWCOMB K, Bilal S, Michael E
    Combining predictive models with future change scenarios can produce credible forecasts of COVID-19 futures.
    PLoS One. 2022;17:e0277521.
    PubMed     Abstract available


  367. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    COVID-19 and Bangladeshi health professionals: Infection status, vaccination and its immediate health consequences.
    PLoS One. 2022;17:e0277022.
    PubMed     Abstract available


  368. PEREZ A, Johnson JK, Marquez DX, Keiser S, et al
    Factors related to COVID-19 vaccine intention in Latino communities.
    PLoS One. 2022;17:e0272627.
    PubMed     Abstract available


  369. LEE H, Noh EB, Kim JE, Oh J, et al
    Influencing factor of COVID-19 vaccination trust and hesitancy in Wonju city, South Korea.
    PLoS One. 2022;17:e0277016.
    PubMed     Abstract available


  370. KAREEM R, Sethi MR, Inayat S, Irfan M, et al
    The effect of COVID-19 vaccination on the menstrual pattern and mental health of the medical students: A mixed-methods study from a low and middle-income country.
    PLoS One. 2022;17:e0277288.
    PubMed     Abstract available


  371. BRACCI A, Nadini M, Aliapoulios M, McCoy D, et al
    Vaccines and more: The response of Dark Web marketplaces to the ongoing COVID-19 pandemic.
    PLoS One. 2022;17:e0275288.
    PubMed     Abstract available


  372. DABROWSKA-LEONIK N, Sawicka-Powierza J, Bernatowska E, Pac M, et al
    Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age.
    PLoS One. 2022;17:e0277473.
    PubMed     Abstract available


  373. TAMIRE M, Addissie A, Gizaw S, Abebe T, et al
    Household fuel use and its association with potential respiratory pathogens among healthy mothers and children in Ethiopia.
    PLoS One. 2022;17:e0277348.
    PubMed     Abstract available


  374. COCCIA M, Burny W, Demoitie MA, Gillard P, et al
    Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
    PLoS One. 2022;17:e0276505.
    PubMed     Abstract available


  375. LIMANI F, Smith C, Wachepa R, Chafuwa H, et al
    Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study.
    PLoS One. 2022;17:e0277419.
    PubMed     Abstract available


  376. GALDIKIENE L, Jaraite J, Kajackaite A
    Trust and vaccination intentions: Evidence from Lithuania during the COVID-19 pandemic.
    PLoS One. 2022;17:e0278060.
    PubMed     Abstract available


  377. SARRIGEORGIOU I, Moschandreou D, Dimitriadis A, Tsinti G, et al
    Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers.
    PLoS One. 2022;17:e0277827.
    PubMed     Abstract available


  378. LAKNEH EA, Mersha EA, Asresie MB, Belay HG, et al
    Knowledge, attitude, and uptake of human papilloma virus vaccine and associated factors among female preparatory school students in Bahir Dar City, Amhara Region, Ethiopia.
    PLoS One. 2022;17:e0276465.
    PubMed     Abstract available


    January 2021
  379. KIM MH, Son NH, Park YS, Lee JH, et al
    Effect of a hospital-wide campaign on COVID-19 vaccination uptake among healthcare workers in the context of raised concerns for life-threatening side effects.
    PLoS One. 2021;16:e0258236.
    PubMed     Abstract available


  380. ROBERTSON CT, Bentele K, Meyerson B, Wood ASA, et al
    Effects of political versus expert messaging on vaccination intentions of Trump voters.
    PLoS One. 2021;16:e0257988.
    PubMed     Abstract available


  381. BACHELET T, Bourdenx JP, Martinez C, Mucha S, et al
    Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.
    PLoS One. 2021;16:e0257646.
    PubMed     Abstract available


  382. MURAYAMA T, Shimizu N, Fujita S, Wakamiya S, et al
    Predicting regional influenza epidemics with uncertainty estimation using commuting data in Japan.
    PLoS One. 2021;16:e0250417.
    PubMed     Abstract available


  383. ABBASIFARID E, Bolhassani A, Irani S, Sotoodehnejadnematalahi F, et al
    Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
    PLoS One. 2021;16:e0258599.
    PubMed     Abstract available


  384. ZAKHOUR R, Tamim H, Faytrouni F, Khoury J, et al
    Knowledge, attitude and practice of influenza vaccination among Lebanese parents: A cross-sectional survey from a developing country.
    PLoS One. 2021;16:e0258258.
    PubMed     Abstract available


  385. WHELAN J, Marshall H, Sullivan TR
    Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics.
    PLoS One. 2021;16:e0254330.
    PubMed     Abstract available


  386. NAVASCUES M, Budroni C, Guryanova Y
    Disease control as an optimization problem.
    PLoS One. 2021;16:e0257958.
    PubMed     Abstract available


  387. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    PubMed     Abstract available


  388. ROUBY SR, Safwat NM, Hussein KH, Abdel-Ra'ouf AM, et al
    Lumpy skin disease outbreaks in Egypt during 2017-2018 among sheeppox vaccinated cattle: Epidemiological, pathological, and molecular findings.
    PLoS One. 2021;16:e0258755.
    PubMed     Abstract available


  389. WIN TTZ, Campbell A, Magalhaes RJS, Oo KN, et al
    What drives small-scale farmers to vaccinate their multiple livestock species animals against common infectious diseases in Myanmar?
    PLoS One. 2021;16:e0258765.
    PubMed     Abstract available


  390. ALISHAQ M, Nafady-Hego H, Jeremijenko A, Al Ajmi JA, et al
    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
    PLoS One. 2021;16:e0258820.
    PubMed     Abstract available


  391. MALAMBA SS, Muyinda H, Ogwang DM, Katamba A, et al
    Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
    PLoS One. 2021;16:e0251573.
    PubMed     Abstract available


  392. KURTZ SL, De Pascalis R, Meierovics AI, Elkins KL, et al
    Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
    PLoS One. 2021;16:e0249142.
    PubMed     Abstract available


  393. COHEN AA, Yang Z, Gnanapragasam PNP, Ou S, et al
    Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.
    PLoS One. 2021;16:e0247963.
    PubMed     Abstract available


  394. BITAR AN, Zawiah M, Al-Ashwal FY, Kubas M, et al
    Misinformation, perceptions towards COVID-19 and willingness to be vaccinated: A population-based survey in Yemen.
    PLoS One. 2021;16:e0248325.
    PubMed     Abstract available


  395. ARGOTE TIRONI P, Barham E, Zuckerman Daly S, Gerez JE, et al
    Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2021;16:e0259059.
    PubMed     Abstract available


  396. GAO X, Wang L, Zhang H, Zhu B, et al
    Transcriptome analysis and identification of genes associated with floral transition and fruit development in rabbiteye blueberry (Vaccinium ashei).
    PLoS One. 2021;16:e0259119.
    PubMed     Abstract available


  397. ELLIOTT T, Yehia BR, Winegar AL, Raja JK, et al
    Analysis of COVID-19 vaccine non-intent by essential vs non-essential worker, demographic, and socioeconomic status among 101,048 US adults.
    PLoS One. 2021;16:e0258540.
    PubMed     Abstract available


  398. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed     Abstract available


  399. LEONHARDT JM, Ridinger G, Rong Y, Talaei-Khoe A, et al
    Invincibility threatens vaccination intentions during a pandemic.
    PLoS One. 2021;16:e0258432.
    PubMed     Abstract available


  400. TARIQ MH, Bhatti R, Ali NF, Ashfaq UA, et al
    Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach.
    PLoS One. 2021;16:e0258443.
    PubMed     Abstract available


  401. JANG H, Ross TM
    Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    PLoS One. 2021;16:e0258453.
    PubMed     Abstract available


  402. ENRIA L, Bangura JS, Kanu HM, Kalokoh JA, et al
    Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra Leone.
    PLoS One. 2021;16:e0258252.
    PubMed     Abstract available


  403. SOWE A, Njie M, Sowe D, Fofana S, et al
    Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    PLoS One. 2021;16:e0258961.
    PubMed     Abstract available


  404. ARNHEIM-DAHLSTROM L, Zarabi N, Hagen K, Bencina G, et al
    Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study.
    PLoS One. 2021;16:e0256642.
    PubMed     Abstract available


  405. GOMES D, Beyerlein A, Katz K, Hoelscher G, et al
    Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany.
    PLoS One. 2021;16:e0259370.
    PubMed     Abstract available


  406. SCHNEIDER JA, Taylor BG, Hotton AL, Lamuda PA, et al
    National variability in Americans' COVID-19 protective behaviors: Implications for vaccine roll-out.
    PLoS One. 2021;16:e0259257.
    PubMed     Abstract available


  407. HYLAND P, Vallieres F, Hartman TK, McKay R, et al
    Detecting and describing stability and change in COVID-19 vaccine receptibility in the United Kingdom and Ireland.
    PLoS One. 2021;16:e0258871.
    PubMed     Abstract available


  408. FANTIN RF, Fraga VG, Lopes CA, de Azevedo IC, et al
    New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates.
    PLoS One. 2021;16:e0258637.
    PubMed     Abstract available


  409. DOHERTY IA, Pilkington W, Brown L, Billings V, et al
    COVID-19 vaccine hesitancy in underserved communities of North Carolina.
    PLoS One. 2021;16:e0248542.
    PubMed     Abstract available


  410. ANDRASIK MP, Broder GB, Wallace SE, Chaturvedi R, et al
    Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    PLoS One. 2021;16:e0258858.
    PubMed     Abstract available


  411. PRENTOE J, Janitzek CM, Velazquez-Moctezuma R, Goksoyr L, et al
    Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
    PLoS One. 2021;16:e0255336.
    PubMed     Abstract available


  412. MUELLER JE, Seanehia J, Yaro S, Trotter CL, et al
    Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns.
    PLoS One. 2021;16:e0253263.
    PubMed     Abstract available


  413. BONAPARTE SC, Adams L, Bakamutumaho B, Barbosa Costa G, et al
    Rabies post-exposure healthcare-seeking behaviors and perceptions: Results from a knowledge, attitudes, and practices survey, Uganda, 2013.
    PLoS One. 2021;16:e0251702.
    PubMed     Abstract available


  414. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.
    PLoS One. 2021;16:e0258743.
    PubMed     Abstract available


  415. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Correction: Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0259922.
    PubMed     Abstract available


  416. HEINE F, Wolters E
    Using moral foundations in government communication to reduce vaccine hesitancy.
    PLoS One. 2021;16:e0259435.
    PubMed     Abstract available


  417. GRAY AN, Martin-Blais R, Tobin NH, Wang Y, et al
    Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection.
    PLoS One. 2021;16:e0259703.
    PubMed     Abstract available


  418. GOMES DE MACEDO BACURAU A, Sato APS, Francisco PMSB
    Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2021;16:e0259640.
    PubMed     Abstract available


  419. KISAKA S, Makumbi FE, Majalija S, Kagaha A, et al
    "As long as the patient tells you it was a dog that bit him, why do you need to know more?" A qualitative study of how healthcare workers apply clinical guidelines to treat dog bite injuries in selected hospitals in Uganda.
    PLoS One. 2021;16:e0254650.
    PubMed     Abstract available


  420. MBULAWA ZZA, Somdyala NI, Mabunda SA, Williamson AL, et al
    High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.
    PLoS One. 2021;16:e0253074.
    PubMed     Abstract available


  421. STOCKELER AM, Schuster P, Zimmermann M, Hanses F, et al
    Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic.
    PLoS One. 2021;16:e0260213.
    PubMed     Abstract available


  422. KIKUTI M, Sanhueza J, Vilalta C, Paploski IAD, et al
    Porcine reproductive and respiratory syndrome virus 2 (PRRSV-2) genetic diversity and occurrence of wild type and vaccine-like strains in the United States swine industry.
    PLoS One. 2021;16:e0259531.
    PubMed     Abstract available


  423. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed     Abstract available


  424. VENKATESAN MM, Ballou C, Barnoy S, McNeal M, et al
    Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    PLoS One. 2021;16:e0259361.
    PubMed     Abstract available


  425. BAUM U, Poukka E, Palmu AA, Salo H, et al
    Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide cohort study.
    PLoS One. 2021;16:e0258704.
    PubMed     Abstract available


  426. ISLAM MR, Oraby T, McCombs A, Chowdhury MM, et al
    Evaluation of the United States COVID-19 vaccine allocation strategy.
    PLoS One. 2021;16:e0259700.
    PubMed     Abstract available


  427. BRESLIN G, Dempster M, Berry E, Cavanagh M, et al
    COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: Applying the theory of planned behaviour.
    PLoS One. 2021;16:e0259381.
    PubMed     Abstract available


  428. GERRETSEN P, Kim J, Caravaggio F, Quilty L, et al
    Individual determinants of COVID-19 vaccine hesitancy.
    PLoS One. 2021;16:e0258462.
    PubMed     Abstract available


  429. SCHERRER JF, Salas J, Wiemken TL, Hoft DF, et al
    Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts.
    PLoS One. 2021;16:e0257405.
    PubMed     Abstract available


  430. PAPAZOGLOU DD, Baretella O, Feller M, Del Giovane C, et al
    Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
    PLoS One. 2021;16:e0260112.
    PubMed     Abstract available


  431. SCHOMMER SK, Harrison N, Linville M, Samuel MS, et al
    Serologic titers to Leptospira in vaccinated pigs and interpretation for surveillance.
    PLoS One. 2021;16:e0260052.
    PubMed     Abstract available


  432. ACEVEDO-VILLANUEVA KY, Renu S, Shanmugasundaram R, Akerele GO, et al
    Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds.
    PLoS One. 2021;16:e0259334.
    PubMed     Abstract available


  433. BRADFIELD Z, Wynter K, Hauck Y, Sweet L, et al
    COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia.
    PLoS One. 2021;16:e0260049.
    PubMed     Abstract available


  434. SINCLAIR DR, Maharani A, Stow D, Welsh CE, et al
    Can vaccination roll-out be more equitable if population risk is taken into account?
    PLoS One. 2021;16:e0259990.
    PubMed     Abstract available


  435. MUHAJARINE N, Adeyinka DA, McCutcheon J, Green KL, et al
    COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    PLoS One. 2021;16:e0259513.
    PubMed     Abstract available


  436. COOKSON D, Jolley D, Dempsey RC, Povey R, et al
    A social norms approach intervention to address misperceptions of anti-vaccine conspiracy beliefs amongst UK parents.
    PLoS One. 2021;16:e0258985.
    PubMed     Abstract available


  437. RAO CY, Robinson T, Huster K, Laws RL, et al
    Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19.
    PLoS One. 2021;16:e0253108.
    PubMed     Abstract available


  438. GOMES LC, Sanson MCG, Brainin P, de Melo MDCV, et al
    Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon.
    PLoS One. 2021;16:e0253752.
    PubMed     Abstract available


  439. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed     Abstract available


  440. VAN EGEREN D, Stoddard M, Novokhodko A, Rogers MS, et al
    Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.
    PLoS One. 2021;16:e0258997.
    PubMed     Abstract available


  441. CHACON-DIAZ C, Zabalza-Barangua A, San Roman B, Blasco JM, et al
    Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.
    PLoS One. 2021;16:e0260288.
    PubMed     Abstract available


  442. DEVI YD, Goswami HB, Konwar S, Doley C, et al
    Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
    PLoS One. 2021;16:e0258645.
    PubMed     Abstract available


  443. YAMAMOTO K, Suzuki M, Ujiie M, Kanagawa S, et al
    Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan.
    PLoS One. 2021;16:e0258357.
    PubMed     Abstract available


  444. ZORIGT T, Furuta Y, Simbotwe M, Ochi A, et al
    Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
    PLoS One. 2021;16:e0258317.
    PubMed     Abstract available


  445. PHATIHATTAKORN C, Wongsa A, Pongpan K, Anuwuthinawin S, et al
    Seroprevalence of Zika virus in pregnant women from central Thailand.
    PLoS One. 2021;16:e0257205.
    PubMed     Abstract available


  446. LUCHEN CC, Mwaba J, Ng'ombe H, Alabi PIO, et al
    Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia.
    PLoS One. 2021;16:e0260552.
    PubMed     Abstract available


  447. MENA G, Casas I, Casan C, Aunon M, et al
    Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
    PLoS One. 2021;16:e0260397.
    PubMed     Abstract available


  448. CAPITINE IPU, Macicame IB, Uanela AM, Bhatt NB, et al
    Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
    PLoS One. 2021;16:e0260126.
    PubMed     Abstract available


  449. ANJORIN AA, Odetokun IA, Abioye AI, Elnadi H, et al
    Will Africans take COVID-19 vaccination?
    PLoS One. 2021;16:e0260575.
    PubMed     Abstract available


  450. BRAILOVSKAIA J, Schneider S, Margraf J
    To vaccinate or not to vaccinate!? Predictors of willingness to receive Covid-19 vaccination in Europe, the U.S., and China.
    PLoS One. 2021;16:e0260230.
    PubMed     Abstract available


  451. IOANNOU GN, Green P, Locke ER, Berry K, et al
    Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system.
    PLoS One. 2021;16:e0259696.
    PubMed     Abstract available


  452. GUPTA S, Watanabe S, Laurent SM
    Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 pandemic.
    PLoS One. 2021;16:e0260380.
    PubMed     Abstract available


  453. MUSTAPHA M, Lawal BK, Sha'aban A, Jatau AI, et al
    Factors associated with acceptance of COVID-19 vaccine among University health sciences students in Northwest Nigeria.
    PLoS One. 2021;16:e0260672.
    PubMed     Abstract available


  454. ABDOU MS, Kheirallah KA, Aly MO, Ramadan A, et al
    The coronavirus disease 2019 (COVID-19) vaccination psychological antecedent assessment using the Arabic 5c validated tool: An online survey in 13 Arab countries.
    PLoS One. 2021;16:e0260321.
    PubMed     Abstract available


  455. DROPPA-ALMEIDA D, da Silva GA, Gaspar LMDAC, Pereyra BBS, et al
    Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice.
    PLoS One. 2021;16:e0256864.
    PubMed     Abstract available


  456. BARRY M, Temsah MH, Alhuzaimi A, Alamro N, et al
    COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.
    PLoS One. 2021;16:e0244415.
    PubMed     Abstract available


  457. POLLOCK BH, Kilpatrick AM, Eisenman DP, Elton KL, et al
    Safe reopening of college campuses during COVID-19: The University of California experience in Fall 2020.
    PLoS One. 2021;16:e0258738.
    PubMed     Abstract available


  458. GALLANT AJ, Nicholls LAB, Rasmussen S, Cogan N, et al
    Changes in attitudes to vaccination as a result of the COVID-19 pandemic: A longitudinal study of older adults in the UK.
    PLoS One. 2021;16:e0261844.
    PubMed     Abstract available


  459. QAMAR W, Qayum M, Sadiq N
    Assessing the knowledge and skill of vaccination staff at Adult Vaccination Counters for COVID-19 vaccines: Simulated client method.
    PLoS One. 2021;16:e0261286.
    PubMed     Abstract available


  460. FONTENOT HB, Mattheus DB, Lim E, Michel A, et al
    Undergraduate nursing students' COVID-19 vaccine intentions: A national survey.
    PLoS One. 2021;16:e0261669.
    PubMed     Abstract available


  461. MAYAN D, Nguyen K, Keisler B
    National attitudes of medical students towards mandating the COVID-19 vaccine and its association with knowledge of the vaccine.
    PLoS One. 2021;16:e0260898.
    PubMed     Abstract available


  462. YANG C, Yang Y, Li Y
    Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    PLoS One. 2021;16:e0261236.
    PubMed     Abstract available


  463. KING WC, Rubinstein M, Reinhart A, Mejia R, et al
    Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021.
    PLoS One. 2021;16:e0260731.
    PubMed     Abstract available


  464. SUBEDI P, Yadav GK, Paudel B, Regmi A, et al
    Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    PLoS One. 2021;16:e0260638.
    PubMed     Abstract available


  465. FIRSTOVA VV, Shakhova AS, Riabko AK, Silkina MV, et al
    Characterization of the adaptive immune response of donors receiving live anthrax vaccine.
    PLoS One. 2021;16:e0260202.
    PubMed     Abstract available


  466. ROSETTIE KL, Joffe JN, Sparks GW, Aravkin A, et al
    Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis.
    PLoS One. 2021;16:e0260808.
    PubMed     Abstract available


  467. MOHAMMED R, Nguse TM, Habte BM, Fentie AM, et al
    COVID-19 vaccine hesitancy among Ethiopian healthcare workers.
    PLoS One. 2021;16:e0261125.
    PubMed     Abstract available


  468. HORIUCHI S, Sakamoto H, Abe SK, Shinohara R, et al
    Factors of parental COVID-19 vaccine hesitancy: A cross sectional study in Japan.
    PLoS One. 2021;16:e0261121.
    PubMed     Abstract available


  469. THOMPSON J, Wattam S
    Estimating the impact of interventions against COVID-19: From lockdown to vaccination.
    PLoS One. 2021;16:e0261330.
    PubMed     Abstract available



  470. Retraction: Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and Long-Term-siRNA Treatment.
    PLoS One. 2021;16:e0261693.
    PubMed    


  471. KOESNOE S, Masjkuri N, Adisasmita A, Djauzi S, et al
    A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.
    PLoS One. 2021;16:e0250234.
    PubMed     Abstract available


  472. ZENS KD, Baroutsou V, Sinniger P, Lang P, et al
    A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.
    PLoS One. 2021;16:e0247216.
    PubMed     Abstract available


  473. ISSA T, Babi A, Issanov A, Akilzhanova A, et al
    Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    PLoS One. 2021;16:e0261203.
    PubMed     Abstract available


  474. CASAS-DEZA D, Bernal-Monterde V, Aranda-Alonso AN, Montil-Miguel E, et al
    Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes.
    PLoS One. 2021;16:e0261061.
    PubMed     Abstract available


  475. HOSSAIN MB, Alam MZ, Islam MS, Sultan S, et al
    COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey.
    PLoS One. 2021;16:e0260821.
    PubMed     Abstract available


  476. FERWANA I, Varshney LR
    Social capital dimensions are differentially associated with COVID-19 vaccinations, masks, and physical distancing.
    PLoS One. 2021;16:e0260818.
    PubMed     Abstract available


  477. HARGREAVES HEAP SP, Koop C, Matakos K, Unan A, et al
    Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement.
    PLoS One. 2021;16:e0260216.
    PubMed     Abstract available


  478. KADELKA C, McCombs A
    Effect of homophily and correlation of beliefs on COVID-19 and general infectious disease outbreaks.
    PLoS One. 2021;16:e0260973.
    PubMed     Abstract available


  479. GLAZIK R, Moore H, Kennedy D, Bower H, et al
    A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers' perceptions in high and low- and middle-income countries.
    PLoS One. 2021;16:e0260041.
    PubMed     Abstract available


  480. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available


  481. OYO-ITA AE, Hanlon P, Nwankwo O, Bosch-Capblanch X, et al
    Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
    PLoS One. 2021;16:e0257277.
    PubMed     Abstract available


  482. AHSAN A, Dar S, Hassan F, Ghafoor F, et al
    Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.
    PLoS One. 2021;16:e0256816.
    PubMed     Abstract available


  483. MACIUSZEK J, Polak M, Stasiuk K, Dolinski D, et al
    Active pro-vaccine and anti-vaccine groups: Their group identities and attitudes toward science.
    PLoS One. 2021;16:e0261648.
    PubMed     Abstract available


  484. JENSEN EA, Wagoner B, Pfleger A, Herbig L, et al
    Making sense of unfamiliar COVID-19 vaccines: How national origin affects vaccination willingness.
    PLoS One. 2021;16:e0261273.
    PubMed     Abstract available


  485. MIRON VD, Banica L, Sandulescu O, Paraschiv S, et al
    Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.
    PLoS One. 2021;16:e0258798.
    PubMed     Abstract available


  486. LEE MF, Chiang CH, Lin SJ, Wu CS, et al
    Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.
    PLoS One. 2021;16:e0261333.
    PubMed     Abstract available


  487. BERENDAM SJ, Morgan-Asiedu PK, Mangan RJ, Li SH, et al
    Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.
    PLoS One. 2021;16:e0256885.
    PubMed     Abstract available


  488. PEREZ CHACON G, Fathima P, Jones M, Barnes R, et al
    Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.
    PLoS One. 2021;16:e0260388.
    PubMed     Abstract available


  489. VEALS AM, Koprowski JL, Bergman DL, VerCauteren KC, et al
    Occurrence of mesocarnivores in montane sky islands: How spatial and temporal overlap informs rabies management in a regional hotspot.
    PLoS One. 2021;16:e0259260.
    PubMed     Abstract available


  490. GUAN TH, Htut HN, Davison CM, Sebastian S, et al
    Implementation of a neonatal hepatitis B immunization program in rural Karenni State, Myanmar: A mixed-methods study.
    PLoS One. 2021;16:e0261470.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: